 |
|||
 |
 |
 |
|
Clinical Development
This site is for healthcare professionals. If you are not a health care provider please contact your physician.
Progenics' clinical programs are focused in gastroenterology, virology, and oncology - areas of medicine where the Company is seeking to commercialize innovative new products for unmet medical needs. Our clinical studies of investigational drugs are conducted under the supervision of a qualified principal investigator and in accordance with the United States Food and Drug Administration's Good Clinical Practice requirements. At individual study sites, these clinical studies are conducted under the auspices of an Institutional Review Board, which considers ethical factors, the safety of human subjects, and the informed consent disclosure which must be made to participants in the clinical trial. Additional information regarding specific clinical trials can be found on the National Institutes of Health web site www.clinicaltrials.gov.